An Innovative Medicines Initiative Project for Precision Medicine in DKD
This article is over 5 years old, and the information may therefore be outdated. BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes Research Foundation (JDRF) and the sta
https://www.ludc.lu.se/article/innovative-medicines-initiative-project-precision-medicine-dkd - 2026-04-17
